A new study published in the November 1st 2012 issue of the New England Journal of Medicine reveals that Reclast (zoledronic acid) was associated with a significantly reduced risk of vertebral...
(PRWeb November 26, 2012)
Read the full story at http://www.prweb.com/releases/2012/11/prweb10167053.htm